---
created: 2025-04-13
updated: 2025-04-13T10:51
id: "km:ZO#I244"
specialty: neuro
specialty_id: 115
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - source/ak-step1-v11::
  - theme/firstaid::12-neuro-&-special-senses::06-pharm::01-epilepsy-therapy
  - source/ak-step1-v11::
  - theme/firstaid::12-neuro-&-special-senses::06-pharm::01-epilepsy-therapy::phenobarbital
  - source/ak-step1-v11::
  - theme/firstaid::12-neuro-&-special-senses::06-pharm::02-barbiturates
  - source/ak-step1-v11::
  - source/ome-banner
  - source/ak-step1-v11::
  - theme/physeo::09-pharm::14-neuro::04-barbiturates
  - source/ak-step1-v11::
  - theme/sketchypharm::06-neuro/psych::01-sedative-hypnotics::03-barbiturates
  - source/ak-step1-v11::^other::^highyield::2-relativelyhighyield
  - source/ak-step1-v11::^systems::neuro::pharmacology"
type: flashcard
---

# Question
**Phenobarbital** is a first line agent for treatment of seizures in **neonates**

---

# Answer
